Liver
Does “low dose” CBD pose a risk to liver health?
A recent clinical trial raises questions about the safety of widely consumed CBD capsules, gummies, edibles, oils and lotions that are omnipresent in the United States and many other countries. But pioneer cannabis clinician Bonni Goldstein, MD, cautions patients and physicians not to overstate the findings of the new FDA study, which was published in…
Read MoreBeta-Caryophyllene: Terpene Powerhouse
Project CBD recently reported on studies indicating that cannabis terpenes — the compounds that give the plant its robust and distinctive smell — activate the CB1 cannabinoid receptor. What’s more, in the presence of THC (also a CB1 agonist), terpenes appear to modulate cannabinoid activity in varied and interesting ways.1,2 Today we focus on spicy-peppery…
Read More